Franchin, Marcelo 
; Rosalen, Pedro Luiz ; Prado, Douglas da Silva ; Paraluppi, Murilo César; Silva, Rangel Leal ; Damasceno, Luis Eduardo Alves ; morelo, David Fernando Colon ; Napimoga, Marcelo Henrique; Cunha, Fernando de Queiroz ; Alves Filho, José Carlos Farias ; Cunha, Thiago Mattar
Source: European Journal of Pharmacology. Unidades: CENA, FMRP
Subjects: DIFERENCIAÇÃO CELULAR, ENCEFALOMIELITE AGUDA DISSEMINADA, DOENÇAS AUTOIMUNES, INFLAMAÇÃO, FARMACOTERAPIA, INTERLEUCINAS, PRÓPOLIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FRANCHIN, Marcelo et al. Cinnamoyloxy-mammeisin, a coumarin from propolis of stingless bees, attenuates Th17 cell differentiation and autoimmune inflammation via STAT3 inhibition. European Journal of Pharmacology, v. 929, p. 1-8, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2022.175127. Acesso em: 01 nov. 2024.APA
Franchin, M., Rosalen, P. L., Prado, D. da S., Paraluppi, M. C., Silva, R. L., Damasceno, L. E. A., et al. (2022). Cinnamoyloxy-mammeisin, a coumarin from propolis of stingless bees, attenuates Th17 cell differentiation and autoimmune inflammation via STAT3 inhibition. European Journal of Pharmacology, 929, 1-8. doi:10.1016/j.ejphar.2022.175127NLM
Franchin M, Rosalen PL, Prado D da S, Paraluppi MC, Silva RL, Damasceno LEA, morelo DFC, Napimoga MH, Cunha F de Q, Alves Filho JCF, Cunha TM. Cinnamoyloxy-mammeisin, a coumarin from propolis of stingless bees, attenuates Th17 cell differentiation and autoimmune inflammation via STAT3 inhibition [Internet]. European Journal of Pharmacology. 2022 ; 929 1-8.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.ejphar.2022.175127Vancouver
Franchin M, Rosalen PL, Prado D da S, Paraluppi MC, Silva RL, Damasceno LEA, morelo DFC, Napimoga MH, Cunha F de Q, Alves Filho JCF, Cunha TM. Cinnamoyloxy-mammeisin, a coumarin from propolis of stingless bees, attenuates Th17 cell differentiation and autoimmune inflammation via STAT3 inhibition [Internet]. European Journal of Pharmacology. 2022 ; 929 1-8.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.ejphar.2022.175127
